Pharma Pulse: Long COVID's Enduring Challenge Amid Major US Manufacturing Surge
While studies reveal the complex, varying, and long-lasting burden of Long COVID symptoms, biopharma giants Novartis and Moderna commit significant capital to new facilities, reinforcing US drug supply resilience in today’s Pharma Pulse.
2m
•
Nov 21, 2025